Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2

NCT00281658 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

444

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Breast

Interventions

DRUG: Lapatinib (GW572016) oral tablets
DRUG: Paclitaxel infusion
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals